While most cardiovascular research has traditionally focused on the heart and large blood vessels, a growing body of evi...
As obesity treatment enters a new phase of innovation, the industry is increasingly looking beyond GLP-1 therapies to ad...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
US-based Natera, Inc., a global leader in cell-free DNA and precision medicine, has announced that Signatera has re...
China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
Few therapeutic areas have witnessed the level of progress achieved in HIV over the past three decades...
While antimicrobial resistance (AMR) is often overshadowed by high-profile therapeutic areas such as oncology, its growi...
Artificial intelligence has long promised to transform healthcare, yet widespread adoption has often been hindered by ch...
Alzheimer's disease research has entered a pivotal new phase following the arrival of the first disease-modifying therap...
Indian startup IHLD MedTech has announced a strategic investment from UltraGreen.ai, a global leader in fluorescence-gui...
US-based Thermo Fisher Scientific has expanded its LABScreen™ Single Antigen ExPlex Portfolio with ...
As cannabis use expands globally and regulatory frameworks continue to evolve, healthcare systems are increasingly confr...
Autoimmune and inflammatory diseases frequently affect the eye, yet ophthalmology has largely remained on the sidelines ...
Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary soluti...
China-based CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that as...
The search for safer and more effective pain therapies remains one of medicine's most pressing challenges. Despite advan...
As the global burden of cardiometabolic disease continues to rise, researchers are increasingly looking beyond tradition...
The COVID-19 pandemic demonstrated that scientific discovery can move at extraordinary speed, but it also expose...
As artificial intelligence reshapes the future of genomic medicine, WhiteLab Genomics is positioning itself at t...
Artificial intelligence is rapidly transforming biologics discovery, but the industry's focus is shifting from generatin...
Despite decades of advances in oncology, many solid tumours remain difficult to treat effectively without exposing patie...
Chime Biologics, a global biologics contract development and manufacturing organisation (CDMO), has announced the inaugu...
As advanced therapeutics move from scientific promise to commercial reality, the industry's focus is shifting be...
The RNA revolution is entering a new chapter. While mRNA transformed the industry's perception of nucleic acid therapeut...
Cancer drug discovery is entering a more disciplined era. Investors, partners, and clinicians are increasingly focused o...
